Skip to content

Nurse-Led Empowerment: Evaluating a Proposed Telephone Follow-up Care for Breast Cancer Survivors in India.

A Formative Evaluation of a Proposed Nurse-Led Telephone Follow-up for Breast Cancer Patients in India - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/066272
Enrollment
115
Registered
2024-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C501- Malignant neoplasm of central portion of breast

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Curtin University, Kent Street, Bentley, Western Australia, WA6102
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients who have completed treatment for breast cancer in the last six months 2. Are able to converse in Hindi/ Punjabi 3.Have the capacity to give informed consent 4. Doctors and nurses who work in outpatient clinics and other related specialties being studied (Oncology and Surgery)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1.Need, feasibility and acceptability of a proposed nurse-led telephone follow-up care service for women with breast cancer post discharge.Timepoint: Baseline and 4 weeks

Secondary

MeasureTime frame
1. Impact of symptoms and problems experienced by women on their QOL 2. Health professionals knowledge and attitude regarding the current follow-up procedures and treatment. remission after breast cancer treatment. 3. Strategies to improve psychosocial coping in breast cancer women undergoing treatment and during follow upTimepoint: Time points will be 2 to 3 years for all.

Countries

India

Contacts

Public ContactDR BUDHI SINGH YADAV

Curtin University

ambili.nair@curtin.edu.au0061402604257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026